Cargando…
Molecular markers associated with outcome and metastasis in human pancreatic cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous cancer in which differences in survival rates might be related to a variety in gene expression profiles. Although the molecular biology of PDAC begins to be revealed, genes or pathways that specifically drive tumour progression o...
Autores principales: | Van den Broeck, Anke, Vankelecom, Hugo, Van Eijsden, Rudy, Govaere, Olivier, Topal, Baki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511800/ https://www.ncbi.nlm.nih.gov/pubmed/22925330 http://dx.doi.org/10.1186/1756-9966-31-68 |
Ejemplares similares
-
Human pancreatic adenocarcinoma contains a side population resistant to gemcitabine
por: Van den broeck, Anke, et al.
Publicado: (2012) -
Human Pancreatic Cancer Contains a Side Population Expressing Cancer Stem Cell-Associated and Prognostic Genes
por: Van den broeck, Anke, et al.
Publicado: (2013) -
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
por: Janky, Rekin’s, et al.
Publicado: (2016) -
The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis
por: Wouters, Jasper, et al.
Publicado: (2013) -
Pancreatic cancer circulating tumour cells express a cell motility gene signature that predicts survival after surgery
por: Sergeant, Gregory, et al.
Publicado: (2012)